# carbidopa, levodopa and entacapone

NDC: 62332-795
Generic name: carbidopa, levodopa and entacapone
Labeler / Manufacturer: Alembic Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20260212

FDA application: ANDA218535

## Active ingredients

- CARBIDOPA: 12.5 mg/1
- ENTACAPONE: 200 mg/1
- LEVODOPA: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62332-795"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62332-795
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9d4e886e-edec-471d-b619-bf4828a6b7ce